IBM Acquires HashiCorp From Mitchell Hashimoto And Armon Dadgar

IBM has completed its $6.4 billion acquisition of HashiCorp, following regulatory approval from the U.K.'s Competition and Markets Authority and the U.S. Federal Trade Commission. The deal, first announced 10 months ago, strengthens IBM’s hybrid cloud strategy by integrating HashiCorp’s infrastructure automation tools, including Terraform. HashiCorp, founded by Mitchell Hashimoto and Armon Dadgar, had shifted Terraform to a proprietary license in 2023, making it a more attractive acquisition target. This move aligns with IBM’s broader cloud and AI ambitions, following major acquisitions like Red Hat ($34B) and Apptio ($4.6B). BUYER: IBM SELLER: HashiCorp SALE PRICE: $6,400,000,000 IBM HQ: #NewYork #NY #NewYorkCity #NYC HashiCorp HQ: #SanFrancisco #California #VentureCapital #IBM #HashiCorp #MitchellHashimoto #ArmonDadgar #TradedVC

More Deals

View All

Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts. FOUNDERS: Ben Lamm & George Church TARGET VALUATION: $23,000,000,000 HQ: Dallas, Texas #VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC